Ascendis Pharma A/S Total Non Current Liabilities 2011-2026 | ASND

Annual Total Non Current Liabilities Ascendis Pharma A/S

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	101 M	88.3 M	31.6 M	-	-	-	-	-	-	-	213 K

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
101 M	213 K	55.3 M

Quarterly Total Non Current Liabilities Ascendis Pharma A/S

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	609 M	101 M	95.6 M	94.1 M	89.6 M	88.3 M	30.1 M	29.1 M	30.8 M	31.6 M	31.5 M	31.5 M	13.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in EUR currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
609 M	13.2 M	98.1 M

Total Non Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Non Current Liabilities	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
Albireo Pharma ALBO	79.1 M	-	-0.23 %	$ 916 M	USA
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	184 M	-	2.54 %	$ 160 B	France
Aileron Therapeutics ALRN	4.59 M	-	10.36 %	$ 9.8 M	USA
Altimmune ALT	4.4 M	$ 3.44	2.99 %	$ 303 M	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Amgen AMGN	37.2 B	$ 349.77	0.57 %	$ 188 B	USA
Amphastar Pharmaceuticals AMPH	69.4 M	$ 19.23	-1.38 %	$ 899 M	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Amarin Corporation plc AMRN	31.7 M	$ 14.6	0.76 %	$ 6.06 B	Irlanda
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Inventiva S.A. IVA	13.8 M	$ 6.08	5.19 %	$ 138 M	France
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Advaxis ADXS	16 M	-	-9.65 %	$ 45.9 M	USA
Avenue Therapeutics ATXI	2.03 M	-	-52.27 %	$ 4.45 M	USA
Autolus Therapeutics plc AUTL	50.6 M	$ 1.4	2.19 %	$ 357 M	Britain
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
ChemoCentryx CCXI	81.7 M	-	-	$ 3.74 B	USA
Aytu BioScience AYTU	42.1 M	$ 2.63	0.77 %	$ 16.5 M	USA
Atreca BCEL	12.6 M	-	-11.76 %	$ 5.79 M	USA
BioDelivery Sciences International BDSI	78.7 M	-	-4.8 %	$ 255 M	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
BeiGene, Ltd. BGNE	2 B	-	0.49 %	$ 251 B	Cayman-islands
Bellerophon Therapeutics BLPH	1.93 M	-	-74.18 %	$ 955 K	USA
Benitec Biopharma BNTC	213 K	$ 11.19	1.91 %	$ 461 M	USA
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Arbutus Biopharma Corporation ABUS	25.6 M	$ 4.42	4.25 %	$ 734 M	Canada
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Allakos ALLK	8.11 M	-	-	$ 28.6 M	USA
Brickell Biotech BBI	146 K	-	-5.38 %	$ 6.06 M	USA
Allena Pharmaceuticals ALNA	10.2 M	-	3.16 %	$ 1.9 M	USA
Cabaletta Bio CABA	43.9 M	$ 2.82	-4.08 %	$ 3.29 M	USA
Calithera Biosciences CALA	4.82 M	-	-10.95 %	$ 876 K	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
Cara Therapeutics CARA	3.35 M	-	-3.03 %	$ 260 M	USA
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA